We are BDD.
At BDD we develop, manufacture and clinically test pharmaceutical products. We offer a single point solution to get phase I clinical data faster by eliminating unnecessary steps that cost our clients time and money.
We call this Lean Clinical Development™
Contera Pharma and BDD Pharma announce dosing of first subject in a Phase 1 trial of CP-012, a novel formulation to treat nocturnal symptoms and morning akinesia in Parkinson´s disease